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derangement of liver architecture caused by ﬁbrosis
and nodule formation, which confers to the liver the typ-
ical aspect of a bag ﬁlled with nuts (Fig. 1a and b). Its
diagnosis requires pathological examination of a liver
sample, usually obtained using a liver biopsy needle.
Liver biopsy however is an invasive procedure, unpleas-
ant for the patient, expensive, not free from severe com-
plications, and prone to sampling errors due to the very
small size of needle biopsy specimens [1–4]. Because of
this, a number of non-invasive tests have been proposed
to identify the presence of cirrhosis.
Identifying transition to cirrhosis is clinically relevant
in many chronic liver diseases, from chronic hepatitis
(viral or autoimmune) to alcoholic, genetic, metabolic
liver disease (non-alcoholic fatty liver disease) and
cholestatic disorders. This is due to the fact that once
cirrhosis is present most patients will develop portal
hypertension, which precedes clinical decompensation
and that calls for speciﬁc investigations to institute
appropriate therapy [5,6].
In recent years, the advent of transient elastography
(TE) using Fibroscan has emerged as a very useful tool
for the non-invasive diagnosis of signiﬁcant ﬁbrosis and
cirrhosis in patients with chronic hepatitis C (CHC)
virus infection. While in other causes of liver disease
the potential of TE has not yet been well established,0168-8278/$34.00  2008 European Association for the Study of the Liver.
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that TE is of real clinical utility and that its use may save
a substantial number of liver biopsies. This is well illus-
trated by the ﬁndings presented in the article by Castera
et al. [7] in the current issue of Journal of Hepatology, as
well as by many previous studies by the same group and
others [8–12].
The only important limitation for the use TE is the
impossibility of obtaining adequate measurements in a
large fraction of obese patients and of those with ascites.
Obviously, the one that counts the most in the evalua-
tion of transition to cirrhosis is overweight since in most
instances ascites is a sign of advanced cirrhosis. In this
regard it is worth noting that in the study by Castera
et al. [7] overweight precluded correct TE measurements
in a very low number of patients (3%), much below what
would be expected in a French population of (extremely)
well nourished middle aged men and women. So some
selection bias may have been present. In our own expe-
rience in Barcelona, where quality of food and wine is
hopefully close to that in Paris (but probably not better),
failure of TE due to overweight is of about 9%.
Although this diﬀerence is rather small quantitatively,
it will have a bigger impact on the ﬁgures of the ‘‘inten-
tion to treat” analysis, by increasing the number of sub-
jects with indeterminate values. However, this will not
detract from the validity of their observations.
Another important aspect of the paper is the conﬁr-
mation that TE is not a good method to obviate the
need of endoscopy to screen for varices in patients with
TE values above the cirrhosis threshold or higher
cut-oﬀs [13,14]. This is not surprising since despite anPublished by Elsevier B.V. All rights reserved.
Fig. 1. The nut/cirrhosis connection: (a) an extirped cirrhotic liver; (b)
nut ﬁlled bag; (c) peritoneoscopic view of the nodular surface of a
cirrhotic liver; (d) ultrasonographic view of the nodules on the liver
margin using a high frequency transducer (by courtesy of Dr. J.M.
Bordas and Dr. A. Berzigotti). [This ﬁgure appears in colour on the web.]
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formation of varices [6], in itself the magnitude of the
portal pressure elevation does not correlate with either
the presence or size of varices. Thus, the fact that TE
values in cirrhosis due to HCV correlate with HVPG
values [12,15] it is not helpful in identifying patients with
varices. Besides, when varices are detected by a non-
endoscopic procedure (i.e. radiology), endoscopy should
be performed to evaluate other important aspects that
inﬂuence therapeutic decisions, independently of the
varices being small or large such as presence of red col-
our signs, of gastric varices or of other concomitant
lesions [16].
A negative aspect of the study is that the comparison
with other non-invasive methods of diagnosing cirrhosis
did not include any imaging technique. This takes us
back to the bag full of nuts (Fig. 1b). TE senses the
hardness of the nuts, but misses the nodules. It is impor-
tant to remember that for many years cirrhosis was diag-
nosed at laparoscopy, precisely by seeing a nodular liver
surface [4,2] (Fig. 1c). A number of studies even showed
that diagnosis of cirrhosis was more reliable by periton-
eoscopy than by liver biopsy, since the latter may not
demonstrate cirrhosis in an unequivocally cirrhotic liver,
due to the small size of liver tissue obtained by needle
biopsy [2,4]. Current imaging techniques have such a
resolution that it is hard to believe that they can not
show a nodular liver surface [13]. Even very simple tech-
niques, like ultrasonography using a high frequency
transducer have a very high resolution and should allow
observation of nodules on the liver surface (Fig. 1d). It is
likely therefore that the combination of TE and liver
ultrasound (or another imaging technique) may have a
greater accuracy in detecting cirrhosis than TE alone.As in many other circumstances, not only in science, see-
ing is believing!
Finally, the study by Castera et al. [7] clearly shows
that the role of currently available non-imaging methods
to diagnose cirrhosis, based on diﬀerent combinations of
serum markers of ﬁbrosis and haematological or bio-
chemical parameters, have very limited value if any.
Clearly, these are not appropriate to validate any new
non-invasive technique since its diagnostic yield is much
below that aﬀorded by TE, which is emerging as the test
to be beaten by future developments.Acknowledgements
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